Healthcare > Crohn’s disease

Tracking since May 19, 2026 · Latest signal Apr 22, 2026 · 8 matched data points

Overall sentiment

Positive 50% (4)Negative 0% (0)Neutral 50% (4)

Daily sentiment

Claims (1)

Claims contributing to this aggregate. Confirmed negative claims count as negative impact; confirmed positive claims count as positive impact.

GM-CSF plays a regulatory role in preventing the loss of ILC3 populations and inhibiting pro-inflammatory cytokine production during gut inflammation in Crohn’s disease.

Parent: HealthcareEntity: Crohn’s diseaseImpact: positiveDate: Apr 22, 2026Target: GM-CSF's role in managing gut inflammation in Crohn’s disease8 matched entries4 confirmed0 disputed4 neutral0 unclear